Triple-negative breast cancer (TNBC), characterized by the absence of ER, PR, and HER2 receptors, remains one of the most aggressive breast cancer subtypes, with limited therapeutic options and a high
CD4 + T cells are crucial in shaping response and resistance to immunotherapy. To enhance our understanding of their multifaceted functions, we developed copper-64–radiolabeled nanobodies targeting th
The integration and parallelization of nanopore sensors are essential for improving the throughput of nanopore measurements. Solid-state nanopores traditionally have been used in isolation, which prev
Many materials are now recycled, but this is still practically impossible with diapers. Researchers led by Dr. Anne Zeck have now succeeded in breaking down the cellulose in this composite material wi
Current Tenders For our tenders, the NMI uses the subreport ELViS award platform . There, we make all award documents available for download, in particular the specifications, the award criteria and f
MIK - MDR- & IVDR-Competence Centre Dr. Hanna Hartmann Head of Biomedicine & Material Sciences Group Leader Regenerative Biomaterials +49 7121 51530-872 E-Mail anzeigen Dr. Xin Xiong Group Leader Biop
The partners in the HEAL-X Bioink project are currently spending a whole week at the NMI. Colleagues from TU Darmstadt and the Max Planck Institute for Polymer Research are at the institute to carry o
Former NMI researcher Dr. Johanna Heider has been awarded the Reinhold and Maria Teufel Foundation Prize. She received the prize in the field of biology. Former NMI researcher Dr. Johanna Heider has b
Kick-off for the SoftPrint project: Representatives from NMI and the University of Stuttgart's Institute for Interfacial Engineering and Plasma Technology met yesterday in Reutlingen to launch their j
The NMI is turning 40 years old and we are celebrating with an open day. On Friday, September 19, 2025 from 1pm until 5pm, there will be guided tours, information stands and other activities to give y
